PanTera aims to secure the large-scale production of actinium-225 (Ac-225), targeting its use in radiopharmaceuticals for personalized cancer treatment. The company focuses on improving the accessibility of innovative cancer therapies based on Ac-225.
peer of
competitor of
Metrics
marketPRIVATE
msh_idCOM:PANTERA-LIFE
localebe
websitehttps://pantera-life.com/
source_refc0c1ac2c-2d9f-4dca-bf3a-9fedf5209737
products_or_servicesProduction of actinium-225 (Ac-225) for use in targeted radiotherapy for cancer treatment.
Belgium